Joshua Wood, PhD, recently published an article in association with the American Association for the Study of Liver Diseases. Josh serves as our VP of Clinical Operations at StemExpress. “Although the vasculogenic potential of circulating and cord blood (CB)-derived endothelial colony-forming cells (ECFC) has been demonstrated in vitro and in vivo, little is known about the inherent biologic ability of these cells to home to different organs and contribute to tissue-specific cell populations.”
